Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
422 studies found for:    "Venous Thromboembolism"
Show Display Options
Rank Status Study
1 Completed
Has Results
Use of Oral Contraceptives (OCs) Containing Dienogest and Risk of Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
2 Completed Increased Rate of Prophylaxis Against Venous Thromboembolism Due to eAlerts
Condition: Venous Thromboembolism
Intervention: Behavioral: electronic alerts
3 Recruiting Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Sodium enoxaparin;   Drug: Sodium Enoxaparin clexane
4 Completed
Has Results
The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin sodium;   Drug: Dalteparin sodium/aspirin
5 Terminated
Has Results
Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients
Condition: Venous Thromboembolism
Interventions: Drug: Dalteparin (Fragmin);   Drug: Unfractionated heparin
6 Unknown  Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Nadroparin
7 Terminated
Has Results
D-dimer to Predict Recurrence in Patients With Multiple Episodes of Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention: Drug: Warfarin
8 Completed Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With Cancer
Condition: Venous Thromboembolism
Intervention:
9 Completed Evaluation of Venous Thromboembolism (VTE) Prophylaxis in Medically Ill Patients
Condition: Venous Thromboembolism
Intervention: Behavioral: Education
10 Completed Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention: Drug: YM150
11 Completed Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: Semuloparin Sodium;   Drug: Enoxaparin sodium;   Drug: Placebo
12 Completed Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005
Condition: Venous Thromboembolism
Intervention:
13 Completed YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness
Condition: Venous Thromboembolism
Intervention: Drug: YM150
14 Completed The Swiss Venous Thromboembolism Cohort 65+
Condition: Venous Thromboembolism
Intervention:
15 Completed Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.
Condition: Venous Thromboembolism
Intervention:
16 Withdrawn Systematic Review and Meta-Analysis of Venous Thromboembolism (VTE) Risk Assessment in Hospitalized Medical Patients
Condition: Venous Thromboembolism
Intervention: Other: Application of VTE Risk Assessment
17 Completed A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Condition: Venous Thromboembolism
Interventions: Drug: YM150;   Procedure: mechanical prophylaxis
18 Active, not recruiting Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty
Condition: Venous Thromboembolism
Intervention: Drug: rivaroxaban and ASA
19 Unknown  ICU Venous Thromboembolism Incidence Study in a Chinese Population
Condition: Venous Thromboembolism
Intervention:
20 Unknown  Optimal Prophylactic Method of Venous Thromboembolism (VTE)
Condition: Venous Thromboembolism
Intervention: Drug: low molecular weight heparin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.